N-(Anilinoethyl)amides: design and synthesis of metabolically stable, selective melatonin receptor ligands.
about
Melatonin in aging and disease -multiple consequences of reduced secretion, options and limits of treatment.Unveiling the role of melatonin MT2 receptors in sleep, anxiety and other neuropsychiatric diseases: a novel target in psychopharmacology.Investigational melatonin receptor agonists.MT1-selective melatonin receptor ligands: synthesis, pharmacological evaluation, and molecular dynamics investigation of N-{[(3-O-substituted)anilino]alkyl}amides.
P2860
N-(Anilinoethyl)amides: design and synthesis of metabolically stable, selective melatonin receptor ligands.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
N-(Anilinoethyl)amides: design ...... ve melatonin receptor ligands.
@en
N-(Anilinoethyl)amides: design ...... ve melatonin receptor ligands.
@nl
type
label
N-(Anilinoethyl)amides: design ...... ve melatonin receptor ligands.
@en
N-(Anilinoethyl)amides: design ...... ve melatonin receptor ligands.
@nl
prefLabel
N-(Anilinoethyl)amides: design ...... ve melatonin receptor ligands.
@en
N-(Anilinoethyl)amides: design ...... ve melatonin receptor ligands.
@nl
P2093
P50
P356
P1433
P1476
N-(Anilinoethyl)amides: design ...... ve melatonin receptor ligands.
@en
P2093
Alessandro Fioni
Alessia Caronno
Caterina Carmi
Claudia Silva
Francesco Scaglione
Giorgio Tarzia
Marilou Pannacci
Pierfrancesco Orlando
Valeria Lucini
P304
P356
10.1002/CMDC.200900240
P50
P577
2009-10-01T00:00:00Z